These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 26147609
21. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Comtois R, Beauregard H, Hardy J, Robert F, Somma M. Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915 [Abstract] [Full Text] [Related]
22. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease. Rak B, Maksymowicz M, Pękul M, Zieliński G. Front Endocrinol (Lausanne); 2021 Jun; 12():672178. PubMed ID: 34135861 [Abstract] [Full Text] [Related]
23. Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases. Felix IA, Horvath E, Kovacs K. Acta Neurochir (Wien); 1981 Jun; 58(3-4):235-43. PubMed ID: 6172012 [Abstract] [Full Text] [Related]
24. Pituitary corticotroph adenoma with crooke's hyalinization. Franscella S, Favrod-Coune CA, Pizzolato G, Asa SL, Gaillard R, Berney J, Philippe J. Endocr Pathol; 1991 Jun; 2(2):111-116. PubMed ID: 32357610 [Abstract] [Full Text] [Related]
25. Surgical treatment of Cushing's disease. Chandler WF, Schteingart DE, Lloyd RV, McKeever PE, Ibarra-Perez G. J Neurosurg; 1987 Feb; 66(2):204-12. PubMed ID: 3806203 [Abstract] [Full Text] [Related]
26. An ACTH and FSH producing invasive pituitary adenoma with Crooke's hyalinization. Kamijo K, Sato M, Saito T, Yachi A, Minase T, Noro H, Kawahara T. Pathol Res Pract; 1991 Jun; 187(5):637-41. PubMed ID: 1717963 [Abstract] [Full Text] [Related]
27. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F. J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398 [Abstract] [Full Text] [Related]
28. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease. Erfe JM, Perry A, McClaskey J, Inzucchi SE, James WS, Eid T, Bronen RA, Mahajan A, Huttner A, Santos F, Spencer D. J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854 [Abstract] [Full Text] [Related]
29. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Cannavò S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, Trimarchi F, Ambrosi B. Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521 [Abstract] [Full Text] [Related]
30. Pituicytoma in a patient with Cushing's disease: case report and review of the literature. Schmalisch K, Schittenhelm J, Ebner FH, Beuschlein F, Honegger J, Beschorner R. Pituitary; 2012 Dec; 15 Suppl 1():S10-6. PubMed ID: 20945102 [Abstract] [Full Text] [Related]
31. Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review. Gilis-Januszewska A, Wilusz M, Pantofliński J, Turek-Jabrocka R, Sokołowski G, Sowa-Staszczak A, Kluczyński Ł, Pach D, Zieliński G, Hubalewska-Dydejczyk A. Endokrynol Pol; 2018 Dec; 69(3):306-312. PubMed ID: 29319131 [Abstract] [Full Text] [Related]
32. Clinico-pathological study of Cushing's disease with large pituitary adenoma. Ikeda H, Yoshimoto T, Ogawa Y, Mizoi K, Murakami O. Clin Endocrinol (Oxf); 1997 Jun; 46(6):669-79. PubMed ID: 9274697 [Abstract] [Full Text] [Related]
33. FSH-producing macroadenoma associated in a patient with Cushing's disease. Oyama K, Yamada S, Hukuhara N, Hiramatsu R, Taguchi M, Yazawa M, Matsuda A, Ohmura E, Imai Y. Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002 [Abstract] [Full Text] [Related]
34. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242 [Abstract] [Full Text] [Related]
36. Crooke's cell tumors of the pituitary. Di Ieva A, Davidson JM, Syro LV, Rotondo F, Montoya JF, Horvath E, Cusimano MD, Kovacs K. Neurosurgery; 2015 May; 76(5):616-22. PubMed ID: 25635886 [Abstract] [Full Text] [Related]
37. Effect of primary empty sella syndrome on pituitary surgery for Cushing's disease. Mehta GU, Bakhtian KD, Oldfield EH. J Neurosurg; 2014 Sep; 121(3):518-26. PubMed ID: 24857241 [Abstract] [Full Text] [Related]
38. Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone. Fleseriu M, Findling JW, Koch CA, Schlaffer SM, Buchfelder M, Gross C. J Clin Endocrinol Metab; 2014 Oct; 99(10):3718-27. PubMed ID: 25013998 [Abstract] [Full Text] [Related]
39. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease. Leal-Cerro A, Martín-Rodríguez JF, Ibáñez-Costa A, Madrazo-Atutxa A, Venegas-Moreno E, León-Justel A, García-Hernández N, Luque RM, Castaño JP, Cano DA, Soto-Moreno A. Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946 [Abstract] [Full Text] [Related]
40. Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS. Clin Endocrinol (Oxf); 1990 Oct; 33(4):525-37. PubMed ID: 2171817 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]